1. Home
  2. HZO vs ANAB Comparison

HZO vs ANAB Comparison

Compare HZO & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HZO
  • ANAB
  • Stock Information
  • Founded
  • HZO 1998
  • ANAB 2005
  • Country
  • HZO United States
  • ANAB United States
  • Employees
  • HZO N/A
  • ANAB N/A
  • Industry
  • HZO Auto & Home Supply Stores
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HZO Consumer Discretionary
  • ANAB Health Care
  • Exchange
  • HZO Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • HZO 635.6M
  • ANAB 759.5M
  • IPO Year
  • HZO 1998
  • ANAB 2017
  • Fundamental
  • Price
  • HZO $28.57
  • ANAB $16.88
  • Analyst Decision
  • HZO Strong Buy
  • ANAB Buy
  • Analyst Count
  • HZO 6
  • ANAB 11
  • Target Price
  • HZO $42.67
  • ANAB $42.67
  • AVG Volume (30 Days)
  • HZO 222.7K
  • ANAB 635.9K
  • Earning Date
  • HZO 01-23-2025
  • ANAB 03-10-2025
  • Dividend Yield
  • HZO N/A
  • ANAB N/A
  • EPS Growth
  • HZO N/A
  • ANAB N/A
  • EPS
  • HZO 1.65
  • ANAB N/A
  • Revenue
  • HZO $2,431,008,000.00
  • ANAB $57,172,000.00
  • Revenue This Year
  • HZO $1.15
  • ANAB $229.13
  • Revenue Next Year
  • HZO $5.41
  • ANAB N/A
  • P/E Ratio
  • HZO $17.32
  • ANAB N/A
  • Revenue Growth
  • HZO 1.52
  • ANAB 282.17
  • 52 Week Low
  • HZO $22.51
  • ANAB $12.51
  • 52 Week High
  • HZO $38.20
  • ANAB $41.31
  • Technical
  • Relative Strength Index (RSI)
  • HZO 50.36
  • ANAB 53.77
  • Support Level
  • HZO $27.19
  • ANAB $14.76
  • Resistance Level
  • HZO $28.16
  • ANAB $15.63
  • Average True Range (ATR)
  • HZO 1.08
  • ANAB 1.02
  • MACD
  • HZO 0.19
  • ANAB 0.61
  • Stochastic Oscillator
  • HZO 60.81
  • ANAB 94.39

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: